from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1092c/coaA

LFCtreatmentdescriptionclass of inhibitor

-1.453

Amikacinug/mL Amikacintranslation

-0.567

Cap5-10ug/mL Capreomycintranslation

-1.526

Rox10-50 ug/mL Roxithromycintranslation

-0.661

SM2-5 ug/mL Streptomycintranslation

-2.767

Tet5-10 ug/mL Tetracyclinetranslation

0.117

Rif0.2-5ug/mL Rifampicintranscription

-0.408

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.655

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.291

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.330

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.683

Clofazimine10-13 ug/mL Clofaziminerespiration

0.223

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.139

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.652

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.672

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.254

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.256

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.305

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.456

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.110

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.337

KCN5-20 ug/mL Potassium cyaniderespiration

0.580

NaN30.2-2 mM Sodium aziderespiration

-1.140

Nigericin50 uM Nigericinrespiration

-0.390

TRC10-150 ug/mL Triclosanrespiration

0.410

TRZ10-25 ug/mL Thioridazinerespiration

-1.267

Valinomycin0.5-10 uM Valinomycinrespiration

1.022

ZnSO42 mM ZnSO4respiration

1.215

menadione6-10 ug/mL Menadionerespiration

-0.805

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.696

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.551

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.098

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.679

NRP_1Non-replicating persistence stage 1dosRassociated

-0.000

Amp0.2mg/mL AmpicillincellWall

-0.065

Cephalexin20-100 ug/mL CephalexincellWall

-0.041

Cerulenin0.32-5 ug/mL CerulenincellWall

0.613

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.242

EMB10-20 ug/mL EthambutolcellWall

-0.404

Eta12-40 ug/mL EthionamidecellWall

-0.621

INH0.2-0.4 ug/mL IsoniazidcellWall

0.170

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.719

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.725

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.084

BZA0.12 mg/mL BenzamidearomaticAmides

0.426

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.092

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.318

H2O24 mM hydrogen peroxideDNAdamaging

0.107

Levo10 ug/mL LevofloxacinDNAdamaging

0.527

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.098

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.095

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.287

UVUV-irradiationDNAdamaging

0.097

ARP41-4 ug/mL Antitubercular compound ARP4?

0.595

Antimycin12.5-50 ug/mL Antimycin A?

-0.185

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.161

PA_110-50 ug/mL Antitubercular compound PA-1?

1.401

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.683

PA8240.2-2 ug/mL PA-824?

0.992

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.473

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.285

Verapamil50 uM Verapamil?

0.253

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.087

methoxatin10-20 ug/mL Methoxatin?